{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:51:54Z","timestamp":1770684714802,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,3,23]],"date-time":"2016-03-23T00:00:00Z","timestamp":1458691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation Grand Challenges Exploration Initiative","doi-asserted-by":"publisher","award":["OPP1096893"],"award-info":[{"award-number":["OPP1096893"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust fellowship","doi-asserted-by":"publisher","award":["WT098635"],"award-info":[{"award-number":["WT098635"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.vaccine.2016.03.061","type":"journal-article","created":{"date-parts":[[2016,3,26]],"date-time":"2016-03-26T18:57:19Z","timestamp":1459018639000},"page":"2296-2298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Potency of a thermostabilised chimpanzee adenovirus Rift Valley Fever vaccine in cattle"],"prefix":"10.1016","volume":"34","author":[{"given":"Pawan","family":"Dulal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Ashfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian V.S.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan","family":"Charleston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George M.","family":"Warimwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.03.061_bib0105","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2471\/BLT.13.123471","article-title":"Economic benefits of keeping vaccines at ambient temperature during mass vaccination: the case of meningitis A vaccine in Chad","volume":"92","author":"Lydon","year":"2014","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2016.03.061_bib0110","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S0264-410X(01)00433-9","article-title":"Frequency and causes of vaccine wastage","volume":"20","author":"Setia","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.03.061_bib0115","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1016\/j.vaccine.2015.03.084","article-title":"Estimating the costs of the vaccine supply chain and service delivery for selected districts in Kenya and Tanzania","volume":"33","author":"Mvundura","year":"2015","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2016.03.061_bib0120","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1038\/sj.gt.3302618","article-title":"Use of adenoviral vectors as veterinary vaccines","volume":"12","author":"Ferreira","year":"2005","journal-title":"Gene Ther"},{"key":"10.1016\/j.vaccine.2016.03.061_bib0125","doi-asserted-by":"crossref","first-page":"115ra112","DOI":"10.1126\/scitranslmed.3002925","article-title":"Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species","volume":"4","author":"Colloca","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2016.03.061_bib0130","article-title":"A monovalent chimpanzee adenovirus ebola vaccine - preliminary report","author":"Rampling","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.03.061_bib0135","doi-asserted-by":"crossref","first-page":"19ra12","DOI":"10.1126\/scitranslmed.3000490","article-title":"Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass","volume":"2","author":"Alcock","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2016.03.061_bib0140","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/path.1700340418","article-title":"Enzootic hepatitis or rift valley fever: an undescribed virus disease of sheep, cattle and man from East Africa","volume":"34","author":"Daubney","year":"1931","journal-title":"J Pathol Bacteriol"},{"key":"10.1016\/j.vaccine.2016.03.061_bib0145","first-page":"908","article-title":"Rift valley fever in South Africa. 2. The occurrence of human cases in the Orange Free State, the North-Western Cape Province, the Western and Southern Transvaal. B. Field and laboratory investigation","volume":"25","author":"Gear","year":"1951","journal-title":"S Afr Med J"},{"key":"10.1016\/j.vaccine.2016.03.061_bib0150","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4269\/ajtmh.2010.09-0318","article-title":"Epidemiologic and clinical aspects of a Rift Valley fever outbreak in humans in Tanzania, 2007","volume":"83","author":"Mohamed","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2016.03.061_bib0155","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1086\/345671","article-title":"Epidemic Rift Valley fever in Saudi Arabia: a clinical study of severe illness in humans","volume":"36","author":"Al-Hazmi","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.03.061_bib0160","first-page":"61","article-title":"Vaccination for the control of Rift Valley fever in enzootic and epizootic situations","volume":"135","author":"Dungu","year":"2013","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.vaccine.2016.03.061_bib0165","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.trivac.2014.03.001","article-title":"Heat stability of the Rift Valley Fever Virus Clone 13 live vaccines","volume":"3","author":"Daouam","year":"2014","journal-title":"Trials Vaccinol"},{"key":"10.1016\/j.vaccine.2016.03.061_bib0170","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/1743-422X-10-349","article-title":"Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice","volume":"10","author":"Warimwe","year":"2013","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2016.03.061_bib0175","doi-asserted-by":"crossref","first-page":"20617","DOI":"10.1038\/srep20617","article-title":"Chimpanzee adenovirus vaccine provides multispecies protection against Rift Valley fever","volume":"6","author":"Warimwe","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2016.03.061_bib0180","doi-asserted-by":"crossref","first-page":"e0003550","DOI":"10.1371\/journal.pntd.0003550","article-title":"Randomized controlled field trial to assess the immunogenicity and safety of rift valley fever clone 13 vaccine in livestock","volume":"9","author":"Njenga","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2016.03.061_bib0185","doi-asserted-by":"crossref","first-page":"e40385","DOI":"10.1371\/journal.pone.0040385","article-title":"A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity","volume":"7","author":"Dicks","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2016.03.061_bib0190","first-page":"65","article-title":"Rift valley fever","volume":"10","author":"Easterday","year":"1965","journal-title":"Adv Vet Sci"},{"key":"10.1016\/j.vaccine.2016.03.061_bib0195","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4049\/jimmunol.62.2.213","article-title":"Rift Valley Fever: accidental infections among laboratory workers","volume":"62","author":"Smithburn","year":"1949","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.03.061_bib0200","doi-asserted-by":"crossref","first-page":"300ra127","DOI":"10.1126\/scitranslmed.aac5757","article-title":"Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections","volume":"7","author":"Taylor","year":"2015","journal-title":"Sci Transl Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16300573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16300573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T11:03:08Z","timestamp":1717239788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16300573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":20,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0264410X16300573"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.061","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potency of a thermostabilised chimpanzee adenovirus Rift Valley Fever vaccine in cattle","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}